News | October 03, 2023
Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The companies will work with investigators to share the results with the scientific community
Clindamycin Phosphate Gel is used to treat acne
InvaGen has received 5 inspectional observations in Form 483
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated
